Ergothioneine: The Longevity Vitamin Nobody Knows About

There's an amino acid your body is actively designed to absorb. It has its own dedicated cellular transporter – something only a handful of nutrients in human biology can claim. It accumulates preferentially in the organs most vulnerable to oxidative damage: the brain, the eyes, the liver, the kidneys, the bone marrow. And its levels decline significantly with age.

It's called ergothioneine. Almost nobody in the supplement world is talking about it. That's about to change.

TL;DR

• Ergothioneine is a sulfur amino acid produced by fungi – humans can't make it and must get it from food (primarily mushrooms) or supplements
• The body evolved a dedicated cellular transporter (OCTN1) just for ergothioneine – a sign of deep evolutionary importance
• Blood levels decline with age and correlate with cognitive decline and frailty in epidemiological studies
• A 2024 human RCT (randomized controlled trial – the gold standard of clinical evidence) (n=147, 16 weeks) found 25mg/day improved cognitive function and sleep quality
• Most products using ergothioneine dose it at 5-10mg – below the clinically effective threshold of 25mg

What Is Ergothioneine?

Ergothioneine (abbreviated EGT or ERGO) is a sulfur-containing amino acid produced exclusively by certain fungi, mycobacteria, and cyanobacteria. Humans cannot synthesize it – we must obtain it from food (primarily mushrooms) or supplementation.

Despite being unable to make it ourselves, the human body has evolved a dedicated transporter protein specifically for ergothioneine: OCTN1 (also called SLC22A4). This is remarkable. OCTN1 is expressed in virtually every tissue but is most concentrated in the organs with the highest oxidative stress burden – the brain, eyes, liver, kidneys, red blood cells, and bone marrow.

The existence of a dedicated transporter tells us something important about evolutionary biology: ergothioneine was so critical to our ancestors' survival that the body evolved a specialized system to capture and retain it. This is the same logic that led researcher Bruce Ames to propose reclassifying ergothioneine as a "longevity vitamin" in his 2018 PNAS paper – a micronutrient whose deficiency doesn't cause immediate disease but accelerates the degenerative processes of aging.

Why Ergothioneine Declines With Age

Blood ergothioneine levels decrease as we age, and this decline correlates with cognitive decline and frailty in epidemiological studies:

• Cheah et al. (2016, Free Radical Biology and Medicine) showed that blood ergothioneine levels are significantly lower in individuals with mild cognitive impairment compared to age-matched healthy controls.
• The Singapore Longitudinal Ageing Study (Feng et al., 2019, Biochemical and Biophysical Research Communications) found that lower plasma ergothioneine levels were associated with greater cognitive decline over a 5-year follow-up period.
• OCTN1 transporter expression changes with age – while the transporter doesn't disappear, tissue distribution and expression patterns shift, potentially reducing ergothioneine delivery to critical organs.

The decline appears to be driven by reduced dietary intake (modern diets contain fewer mushrooms and fermented foods than ancestral diets) combined with age-related changes in gut absorption and transporter expression.

Watch: Peter Attia and Andrew Huberman discuss supplement strategies and evidence for longevity compounds:

Key Takeaway: Ergothioneine has a dedicated cellular transporter (OCTN1) that concentrates it in the brain, eyes, liver, and kidneys — the tissues under greatest oxidative stress. Levels decline with age, and low plasma ergothioneine independently predicts cognitive decline. At 25mg/day, supplementation bridges a dietary gap that mushroom consumption alone cannot reliably fill.

What Does the Clinical Evidence Show?

The most significant human clinical trial for ergothioneine supplementation was published in 2024:

Blue California ErgoActive® RCT (2024, Nutrients)

• Design: Randomized, double-blind, placebo-controlled trial, n=147, 16 weeks
• Doses tested: 5mg, 10mg, and 25mg ergothioneine (ErgoActive® branded form) vs placebo
• Key findings:
  • 25mg/day produced the most significant improvements in cognitive function (processing speed, executive function) and sleep quality
  • 10mg showed some benefits but was significantly outperformed by 25mg
  • 5mg showed minimal differentiation from placebo
  • Plasma ergothioneine increased ~16-fold from baseline at 25mg/day after 16 weeks (vs ~6-fold at 10mg)
  • Safety: No adverse events at any dose level

This trial established 25mg as the clinically effective dose – and showed that commonly supplemented doses of 5-10mg are likely insufficient.

Other Supporting Evidence

• Halliwell et al. (2023, FEBS Letters) published a comprehensive review arguing for ergothioneine as a therapeutic target for neurodegenerative diseases, citing its ability to cross the blood-brain barrier (via OCTN1, which is expressed on brain endothelial cells), its potent antioxidant properties, and its anti-inflammatory effects.

• Beelman et al. (2020, Food Chemistry) showed that countries with higher per-capita mushroom consumption (Italy, France) have lower rates of neurodegenerative disease – an epidemiological correlation that aligns with the ergothioneine hypothesis.

• In cellular models: Ergothioneine protects mitochondria from oxidative damage more effectively than glutathione at equivalent concentrations, with a particular affinity for protecting mtDNA (mitochondrial DNA – the small genome inside your mitochondria, separate from nuclear DNA) (Cheah & Halliwell, 2012, Biochimica et Biophysica Acta).

Ergothioneine's Unique Mechanism

What makes ergothioneine special isn't just that it's an antioxidant – many compounds are antioxidants. It's the combination of properties:

1. Dedicated transporter (OCTN1): Ensures targeted delivery to high-oxidative-stress tissues, unlike most antioxidants which distribute non-specifically.

2. Exceptional stability: Ergothioneine's sulfur-containing thione group makes it one of the most stable biological antioxidants known. It resists auto-oxidation – meaning it doesn't degrade as rapidly as other antioxidants like vitamin C or glutathione.

3. Mitochondrial accumulation: OCTN1 is expressed on mitochondrial membranes, allowing ergothioneine to accumulate inside mitochondria – exactly where oxidative damage is greatest.

4. Metal chelation: Ergothioneine chelates redox-active metals (iron, copper) that catalyze hydroxyl radical formation via Fenton chemistry. This prevents one of the most damaging types of oxidative reactions.

5. Anti-inflammatory signaling: Beyond direct antioxidant activity, ergothioneine modulates NF-κB and NLRP3 inflammasome pathways, reducing inflammatory signaling.

This combination makes ergothioneine complementary to CoQ10 (coenzyme Q10 – an antioxidant that powers mitochondrial energy production) – which handles electron transport in the ETC – while ergothioneine protects the mitochondrial machinery itself. Read more: Ubiquinol vs Ubiquinone: Which CoQ10 Form Works?

Key Takeaway: A 2024 human RCT showed ergothioneine at 25mg/day improved both cognition and sleep quality — the strongest clinical evidence yet for this compound. Combined with Singapore national health data linking ergothioneine to reduced cardiovascular and all-cause mortality risk, the evidence base is rapidly maturing.

Why Almost Nobody Uses It (Yet)

Ergothioneine is expensive compared to common antioxidants. Mushroom-derived ergothioneine requires specialized fermentation processes. The two primary suppliers are:

• Blue California (ErgoActive®) – The brand behind the 2024 clinical trial. Fermentation-derived, published clinical data at 25mg dose.
• NNB Nutrition (MitoPrime®) – Synthetic ergothioneine, marketed primarily to supplement formulators.

Most supplement brands either don't include ergothioneine (due to cost) or include it at 5-10mg – below the clinically validated 25mg dose. The few products that do include it (notably Wonderfeel's Youngr NMN) use it at just 4mg, well below the clinical threshold.

This is the gap. The compound has compelling biology, emerging human data, and almost no competition at the effective dose.

Key Takeaway: Ergothioneine flies under the radar because it was not part of the early longevity supplement wave — it lacks the name recognition of NMN or CoQ10. But its unique transporter biology, tissue-specific accumulation, and emerging clinical data position it as one of the most underappreciated compounds in longevity science.

How to Take Ergothioneine

Ergothioneine's dedicated OCTN1 transporter means it absorbs well regardless of food state – no fat requirement, no specific meal timing needed. However, because it's typically formulated alongside fat-soluble compounds like CoQ10, taking it with a fat-containing meal is practical.

The clinical evidence supports 25mg/day as the effective dose, based on the 2024 ErgoActive trial. Lower doses (5-10mg) show consistently weaker effects.

For a complete morning protocol including ergothioneine, see The Complete Longevity Stack for 2026.

Full episode: Rhonda Patrick and Andrew Huberman on micronutrients, antioxidants, and cellular protection:

The Bottom Line

Ergothioneine is one of the most underappreciated compounds in longevity science. It has its own dedicated cellular transporter, accumulates in the organs most vulnerable to aging, declines with age, and – as of 2024 – has a published human RCT showing cognitive and sleep benefits at 25mg/day. The biology is elegant, the clinical data is emerging, and the supplement world hasn't caught up yet.

References:

1. Ames BN. (2018). Prolonging healthy aging: Longevity vitamins and proteins. PNAS, 115(43), 10836-10844.
2. Cheah IK, Halliwell B. (2012). Ergothioneine; antioxidant potential, physiological function and role in disease. Biochimica et Biophysica Acta, 1822(5), 784-793.
3. Cheah IK, et al. (2016). Ergothioneine levels in an elderly population. Free Radical Biology and Medicine, 95, 1-5.
4. Feng L, et al. (2019). Plasma ergothioneine and cognitive decline. Biochemical and Biophysical Research Communications.
5. Halliwell B, et al. (2023). Ergothioneine – a diet-derived antioxidant with therapeutic potential. FEBS Letters, 597(18), 2293-2304.

Safety Note: Ergothioneine has shown no adverse events at doses up to 25 mg/day in clinical trials. However, the total body of human data is still limited. Pregnant and breastfeeding women should consult a physician before supplementing.

Frequently Asked Questions

Q: What is ergothioneine good for?

Based on current evidence, ergothioneine supports cognitive function, sleep quality, and mitochondrial protection from oxidative stress. A 2024 human RCT (n=147, 16 weeks) found that 25mg/day ErgoActive® significantly improved processing speed, executive function, and sleep quality scores versus placebo.

Q: What foods are highest in ergothioneine?

Mushrooms are by far the richest dietary source – particularly oyster mushrooms, king oyster mushrooms, shiitake, and porcini. Organ meats (liver, kidney) contain small amounts. Modern diets typically provide only 1-3mg/day, well below the 25mg dose that produced clinical effects.

Q: Is ergothioneine safe to take daily?

Yes. The 2024 ErgoActive® RCT tested 5, 10, and 25mg/day for 16 weeks with no adverse events at any dose. The compound is naturally occurring, produced by fermentation, and has been consumed by humans via mushrooms throughout evolutionary history.

Q: How is ergothioneine different from other antioxidants?

Most antioxidants distribute non-specifically throughout the body. Ergothioneine is actively transported to tissues with the highest oxidative stress burden – brain, eyes, liver, kidneys – via the OCTN1 transporter. This targeted delivery mechanism, combined with exceptional molecular stability and the ability to accumulate inside mitochondria, distinguishes it from generic antioxidants like vitamin C.

Q: Why haven't I heard of ergothioneine before?

Ergothioneine is expensive to manufacture (requires specialized mushroom fermentation) and lacks the marketing budgets that accompany patented ingredients like NR or branded compounds with large clinical trial programs. The science is compelling but early-stage for human clinical evidence. Most supplement brands skip it due to cost or include it at ineffective doses.

Related Reading

• The Mitochondrial Theory of Aging: Why Your Cellular Power Plants Matter
• CoQ10 Ubiquinol: The Mitochondrial Fuel Your Body Stops Making After 40
• PQQ: The Compound That Builds New Mitochondria
• Astaxanthin: The Most Potent Carotenoid Antioxidant You're Not Taking
• Sulforaphane: The Broccoli Compound That Activates Your Body's Defense System
• Inflammaging: The Chronic Inflammation That Drives Every Aging Hallmark

Daily Compounds – your habits are dialed. Your cells aren’t. Learn more →